Registry Stop Signal

Disitamab Vedotin

Disitamab Vedotin is flagged as registry stop signal because public records show a registry stop signal, timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Urothelial Carcinoma

Mechanism: Unknown

Modality: Unknown

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Scores

Risk-signal summary

Registry: 5/5

Timeline: 2/5

Recruitment burden: 3/5

Results availability: 0/5

Program risk: 5/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT05912205 | https://clinicaltrials.gov/study/NCT06157892 | https://clinicaltrials.gov/study/NCT06105008 | https://clinicaltrials.gov/study/NCT06966453 | https://clinicaltrials.gov/study/NCT06210490 | https://clinicaltrials.gov/study/NCT07366840 | https://clinicaltrials.gov/study/NCT06003231

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT05912205Unknown Status Signal (UNKNOWN)stale_update_signal | primary_completion_date_past_signalLow Signalrare_population_signal | strict_eligibility_signal
NCT06157892Low Signal (ACTIVE_NOT_RECRUITING)long_recruitment_duration_signalLow Signalrare_population_signal | strict_eligibility_signal
NCT06105008Registry Stop Signal (WITHDRAWN)stale_update_signalLow Signalrare_population_signal | strict_eligibility_signal
NCT06966453Low Signal (RECRUITING)NoneLow Signalrare_population_signal
NCT06210490Low Signal (RECRUITING)long_recruitment_duration_signalLow Signalrare_population_signal
NCT07366840Low Signal (NOT_YET_RECRUITING)NoneLow Signallarge_enrollment_target_signal | few_sites_large_trial_signal | rare_population_signal
NCT06003231Low Signal (ACTIVE_NOT_RECRUITING)long_recruitment_duration_signalLow Signalrare_population_signal | strict_eligibility_signal